| Bid Price | 384.00p | High Price | 394.00p |
|---|
| Ask Price | 394.00p | Low Price | 377.60p |
|---|
| Open Price | 374.00p | Spread | 2.54% |
|---|
| Prev Close | 368.00p | Volume | 201,321 |
|---|
Maxcyte INC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Jan 13, 2025 | 351.00 | 370.00 | 348.00 | 368.00 | 225,812 |
| Jan 10, 2025 | 362.00 | 362.00 | 348.00 | 351.00 | 33,508 |
| Jan 9, 2025 | 355.00 | 370.00 | 355.00 | 362.00 | 54,199 |
| Jan 8, 2025 | 340.00 | 355.00 | 336.00 | 354.00 | 217,592 |
Maxcyte INC Information
| Name | Maxcyte INC | Index | FTSE AIM 100 |
|---|
| ISIN | US57777K1060 | Epic | MXCT |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Medical Devices | Sector | Healthcare |
|---|
| EMS | 750 | Trading Status | Closed |
|---|
| Shares in Issue | 105.48 m | Prev Close | 368.00p |
|---|
| PE Ratio | | Market Cap | £410.33 m |
|---|
| Div Yield | 0 | Div per Share | $NaN |
|---|
| EPS | -$0.29 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.059621 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 9.812667 | Quick Ratio | 8.98882 |
|---|
Maxcyte INC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 30/12/24 | SELL | John Johnston | NED | 3,000 @ £4.01 | £12,021.00 |
| 30/12/24 | BUY | John Johnston | NED | 3,000 @ £2.93 | £8,796.00 |
| 10/12/24 | BUY | John Johnston | NED | 505 @ £2.93 | £1,478.00 |
| 10/12/24 | SELL | John Johnston | NED | 2,495 @ £3.79 | £9,459.00 |
| 10/12/24 | BUY | John Johnston | NED | 483 @ £2.93 | £1,416.00 |
| 10/12/24 | BUY | John Johnston | NED | 1,121 @ £1.64 | £1,840.00 |
| 10/12/24 | BUY | John Johnston | NED | 891 @ £2.93 | £2,607.00 |
| 10/12/24 | SELL | John Johnston | NED | 505 @ £3.70 | £1,869.00 |
| 06/11/24 | SEXR | Stanley Erck | NED | 47,689 @ $3.72 | $177,198.00 |
| 06/11/24 | EXR | Stanley Erck | NED | 47,689 @ $0.04 | $1,908.00 |
Maxcyte INC News
